Free Trial

Short Interest in Jushi Holdings Inc. (OTCMKTS:JUSHF) Declines By 45.0%

Jushi logo with Medical background

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 1,209,000 shares, a decline of 45.0% from the March 31st total of 2,197,200 shares. Based on an average daily volume of 287,400 shares, the days-to-cover ratio is currently 4.2 days. Approximately 0.8% of the shares of the company are short sold.

Jushi Stock Up 0.2 %

OTCMKTS JUSHF traded up $0.00 on Friday, reaching $0.39. 23,069 shares of the stock traded hands, compared to its average volume of 234,936. Jushi has a 12 month low of $0.22 and a 12 month high of $0.78. The company has a market cap of $76.45 million, a price-to-earnings ratio of -1.44 and a beta of -0.86. The firm's fifty day simple moving average is $0.30 and its 200 day simple moving average is $0.33.

Jushi (OTCMKTS:JUSHF - Get Free Report) last released its earnings results on Wednesday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.02). The company had revenue of $65.86 million during the quarter, compared to analysts' expectations of $64.03 million. As a group, equities research analysts forecast that Jushi will post -0.23 EPS for the current fiscal year.

About Jushi

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Featured Stories

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines